The Phase 2 Study of "(TOX) Preoperative Chemotherapy" Response Rate and Side Effects in [Locally Advanced Operable Gastric Adenocarcinoma] Patients With Docetaxel, Oxaliplatin and Capcitabine
AUTHORS
Seyyed-Hossein Yahyazadeh-Jabbari 1 , Nasser Malekpour 2 , Bahram Salmanian 3 , * , Hossein Foodazi 4 , Masoud Salehi 5 , Farsad Noorizadeh 2
How to Cite: Yahyazadeh-Jabbari S, Malekpour N , Salmanian B , Foodazi H, Salehi M, et al. The Phase 2 Study of "(TOX) Preoperative Chemotherapy" Response Rate and Side Effects in [Locally Advanced Operable Gastric Adenocarcinoma] Patients With Docetaxel, Oxaliplatin and Capcitabine, Int J Cancer Manag. 2013 ; 6(3):e80420.
ARTICLE INFORMATION
International Journal of Cancer Management:
6 (3); e80420
Published Online:
September
30,
2013
Article Type:
Research Article
Received:
April
09,
2013
Accepted:
May
14,
2013
READ FULL TEXT
COMMENTS
LEAVE A COMMENT HERE: